Not Signed In -
Ropinirole |
Requip |
Ropinirole Systematic (IUPAC) name 4-(2-dipropylaminoethyl)-1,3-dihydroindol-2-one Identifiers CAS number 91374-21-9 ATC code N04BC04 PubChem 5095 DrugBank APRD00302 Chemical data Formula C16H24N2O Mol. weight 260.375 g/mol Pharmacokinetic data Bioavailability ? Metabolism ? Half life 6 hours Excretion ? Therapeutic considerations Pregnancy cat. C Legal status ℞ Prescription only Routes Oral Ropinirole (marketed as Req ...
Wikipedia - [full article]
Ropinirole Clinical Trials
- A Comparison of Ropinirole Immediate Release With Ropinirole Prolonged Release in Patients With Advanced Parkinson's
ClinicalTrials.gov Identifier: NCT00331149 - Recruiting
Parkinson's Disease
- A Study To Look At The Starting Dose Of Ropinirole Immediate Release Tablets In Young Patients With Restless Legs Syndrome
ClinicalTrials.gov Identifier: NCT00140712 - Recruiting
Restless Legs Syndrome
- Onset Motor Complications Using REQUIP CR (Ropinirole Controlled-Release) As Add-on Therapy To L-Dopa In Parkinson's
ClinicalTrials.gov Identifier: NCT00363727 - Active, not recruiting
Parkinson's Disease; Dyskinesias
- Pramipexole Conversion to Ropinirole CR
ClinicalTrials.gov Identifier: NCT00275275 - Recruiting
Parkinson Disease
- Trial of Ropinirole in Motor Recovery After Stroke
ClinicalTrials.gov Identifier: NCT00221390 - Recruiting
Cerebrovascular Accident; Hemiparesis
- RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
ClinicalTrials.gov Identifier: NCT00314860 - Active, not recruiting
Restless Legs Syndrome
- REQUIP (Ropinirole Hydrochloride)IR Long-Term Phase 4 Study
ClinicalTrials.gov Identifier: NCT00485069 - Recruiting
Parkinson's Disease
- A study comparing the efficacy, safety, and tolerability of an investigational drug versus placebo or Ropinirole in patients with early Parkinson's Disease
ClinicalTrials.gov Identifier: NCT00036218 - Completed
Parkinson Disease
- Ropinirole in the Treatment of Bipolar Depression
ClinicalTrials.gov Identifier: NCT00314821 - Recruiting
Bipolar Disorder
- Open Label High Dose Ropinirole (Requip) Study for Patients With Parkinson's Disease
ClinicalTrials.gov Identifier: NCT00260793 - Recruiting
Parkinson's Disease
- Ropinirole Controlled Release (CR) as an Adjunctive Agent in the Treatment of Major Depression
ClinicalTrials.gov Identifier: NCT00285727 - Recruiting
Major Depression
- SWITCH:Restless Legs Patients Switched to Ropinirole From Pramipexole
ClinicalTrials.gov Identifier: NCT00344994 - Recruiting
Restless Legs Syndrome
- A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in Treatment of 60 Patients With Refractory Bipolar Depression.
ClinicalTrials.gov Identifier: NCT00335205 - Recruiting
Bipolar Disorder; Major Depressive Disorder
- Converting From Ropinirole Immediate Release (IR) To Ropinirole Controlled-Release for RLS (Restless Legs Syndrome)
ClinicalTrials.gov Identifier: NCT00256854 - Completed
Restless Legs Syndrome
- Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
ClinicalTrials.gov Identifier: NCT00355641 - Recruiting
Restless Legs Syndrome
- Long-Term Study Of Ropinirole In Restless Legs Syndrome
ClinicalTrials.gov Identifier: NCT00329602 - Recruiting
Restless Legs Syndrome
- A Two-Year Open-Label, Randomized, Parallel Group Blinded Assessment Ophthalmologic Safety Study of Pramipexole IR Versus Ropinirole in Early Parkinson''s Disease Patients
ClinicalTrials.gov Identifier: NCT00144300 - Recruiting
Parkinson Disease
- The Effects Of Ropinirole On Mood Or Mild Depression In Patients With Moderate To Severe Restless Legs Syndrome
ClinicalTrials.gov Identifier: NCT00357097 - Recruiting
Moderate to Severe Idiopathic Restless Legs Syndrome (RLS)
- Clinical Evaluation of Ropinirole PR/XR Tablets in Monotherapy for Parkinson's Disease (PD)
ClinicalTrials.gov Identifier: NCT00434304 - Not yet recruiting
Parkinson's Disease
- Clinical Evaluation of Ropinirole CR-RLS ( SK&F106064)Tablets in Restless Legs Syndrome
ClinicalTrials.gov Identifier: NCT00530790 - Not yet recruiting
Restless Legs Syndrome
- A Trial To Assess Switching From Ropinirole, Pramipexole Or Cabergoline To The Rotigotine Transdermal System In Idiopathic Parkinson's Disease
ClinicalTrials.gov Identifier: NCT00242008 - Completed
Parkinson's Disease
- Restless Legs Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole And The Effect Of Food
ClinicalTrials.gov Identifier: NCT00419692 - Completed
Restless Legs Syndrome
- 12-Week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
ClinicalTrials.gov Identifier: NCT00373542 - Completed
Restless Legs
- Parkinson's Disease Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole
ClinicalTrials.gov Identifier: NCT00460148 - Completed
Parkinson's Disease
- A Phase 3, Randomized, Open-Label, Two-Arm, Parallel-Group, Multicenter, Multinational Trial to Compare the Efficacy of Rotigotine Transdermal Patch to That of Ropinirole on Early Morning Motor Impairment and Sleep Disorders in Subjects With Early-Stage,
ClinicalTrials.gov Identifier: NCT00243971 - Completed
Parkinson's Disease
- A Clinical Research Study Evaluating Ropinirole Treatment For Restless Legs Syndrome (RLS)
ClinicalTrials.gov Identifier: NCT00225862 - Completed
Restless Legs Syndrome
- A Clinical Research Study Testing Ropinirole Treatment for Restless Legs Syndrome
ClinicalTrials.gov Identifier: NCT00363857 - Completed
Restless Legs Syndrome
- Ropinirole XR (Extended Release) In Patients With Restless Legs Syndrome
ClinicalTrials.gov Identifier: NCT00197080 - Completed
Restless Legs Syndrome
- A Study To Investigate The Effects Of End Stage Renal Disease And Hemodialysis On The Pharmacokinetics Of Ropinirole
ClinicalTrials.gov Identifier: NCT00422994 - Completed
End Stage Renal Disease
- Effect of Ropinirole on Spinal Cord Reflexes and Restless Legs Syndrome
ClinicalTrials.gov Identifier: NCT00051961 - Completed
Restless Legs Syndrome
Resources
- Requip (Drug Digest)
- Ropinirole (Drug Digest)
email this page
print this page
bookmark this page
feedback on this page
